Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-06

Clinical Trial Update: Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

View source ↗

Summary

A completed clinical trial from Oslo University Hospital investigated trough levels of anti-TNF-alpha therapies in inflammatory bowel disease, including Crohn's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oslo University Hospital | Conditions: Inflammatory Bowel Disease, Crohn's Disease | Status: COMPLETED